Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Matt Costa is our new Professor of Orthopaedic Trauma.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is pleased to welcome Professor Matt Costa to the department, joining from 11 May 2015 as Professor of Orthopaedic Trauma Surgery.

Matt is an internationally recognised clinical academic in orthopaedic trauma , as well as having his own clinical practice in trauma surgery. He joins us from the Warwick Clinical Trials Unit, where until recently he was Professor of Trauma and Orthopaedics.

Matt’s research interest is in clinical and cost effectiveness of musculoskeletal interventions, as well as clinical trials and trial design.

Speaking of his appointment, Professor Costa said: “I’m very excited to be joining the team at NDORMS. Musculoskeletal trauma is a huge issue for patients, the NHS and society more broadly. There are so many areas where we can improve patient care and there is no where in the world better placed to address this need than Oxford. I can’t wait to start at NDORMS and look forward to working with the world-leading academics at the University and the world-leading surgeons at the John Radcliffe Hospital”.

Professor Andrew Carr, Head of NDORMS welcomed Professor Costa and said: "I am delighted that Professor Matt Costa is joining the department. He has an international reputation in surgical trials of trauma and will add significantly to research in this area”.

Similar stories

Neutrophil molecular wiring revealed: transcriptional blueprint of short-lived cells

Researchers publish the first blueprint of transcriptional factors that control neutrophil-driven inflammation in Nature Immunology.

NDORMS joins research partnership to understand links between overlapping long-term conditions

The links between different long-term health conditions will be explored in new research funded with a £2.5million grant from the Medical Research Council.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Researchers show the role of cilia in cartilage health

New research shows that disrupting primary cilia in juvenile, adolescent and early adulthood in cartilage stops it maturing correctly, making it more prone to thinning and the potential for osteoarthritis (OA) in later life.

New research could improve quality of life for Psoriatic Arthritis patients

Professors Laura Coates and Dani Prieto-Alhambra will take major roles in a new European Commission project to develop innovative personalised treatment options for people affected by psoriatic arthritis.